Advertisement

If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)

ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.

ENJOY UNLIMITED ACCES TO C&EN

Business

U.S. Drug Sales Inch Up in 2007

March 17, 2008 | A version of this story appeared in Volume 86, Issue 11

U .S. sales of prescription drugs increased by just 3.8% last year, the lowest growth rate since 1961, according to IMS Health, a provider of health care market intelligence. Murray Aitken, senior vice president of the firm's Healthcare Insight unit, attributes the slow growth to patent expirations, fewer new product approvals, a leveling of Medicare prescriptions, and drug safety issues. Total U.S. prescription sales reached $286.5 billion. IMS forecasts U.S. pharmaceutical sales growth of 3-6% per year through 2012.

Article:

This article has been sent to the following recipient:

0 /1 FREE ARTICLES LEFT THIS MONTH Remaining
Chemistry matters. Join us to get the news you need.